Vor Bio to Participate in Upcoming Investor Conferences
30 August 2023 - 10:00PM
Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering
company, today announced that it will participate in the following
upcoming investor conferences:
Citi’s 2023 18th
Annual BioPharma Conference1x1 Investor Meetings:
Thursday, September 7, 2023 Location: Four Seasons Hotel, Boston,
MA
H.C. Wainwright 25th Annual Global Investment Conference
(Hybrid)Virtual Presentation: Monday, September 11, 2023
Location: Lotte New York Palace Hotel, New York, NY
Baird’s 2023 Global Healthcare Conference
Presentation: Wednesday, September 13, 2023 at 9:05 am ETLocation:
Intercontinental New York Barclay, New York, NY
Morgan Stanley 21st
Annual Global Healthcare ConferenceFireside Chat:
Wednesday, September 13, 2023 at 4:15 pm ETLocation: Sheraton
Hotel, New York, NY
Live webcasts and archived replays of the presentation at the
H.C. Wainwright 25th Annual Global Investment Conference and the
fireside chat at the Morgan Stanley 21st Annual Global Healthcare
Conference will be available on the investors section of
www.vorbio.com.
About Vor BioVor Bio is a clinical-stage cell
and genome engineering company that aims to change the standard of
care for patients with blood cancers by engineering hematopoietic
stem cells to enable targeted therapies post-transplant. For more
information, visit: www.vorbio.com.
Contact:
Media & InvestorsSarah Spencer +1
857-242-6076sspencer@vorbio.com
Vor Biopharma (NASDAQ:VOR)
Historical Stock Chart
From Apr 2024 to May 2024
Vor Biopharma (NASDAQ:VOR)
Historical Stock Chart
From May 2023 to May 2024